NetEase Inc vs Twist Bioscience Corp — how do they compare? NetEase Inc trades at $134.95 (market cap $86.14B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: NetEase Inc is far larger — about 15.8× Twist Bioscience Corp's market cap, and NetEase Inc pays a 2.25% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| NTES | TWST | |
|---|---|---|
Market Cap | $86.14B | $5.45B |
Sector | Media | Health |
52-Week High | $159.34 | $102.88 |
52-Week Low | $109.26 | $24.16 |
Enterprise Value | $62.61B | $5.37B |
Dividend Yield | 2.25% | — |
Trailing returns across standard periods
Latest headlines on both assets
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →